Clinical Study
The Clinical Efficacy and Safety of Ertapenem for the Treatment of Complicated Urinary Tract Infections Caused by ESBL-Producing Bacteria in Children
Table 1
Predisposing factors for urinary tract infection,
(%).
| | Neurological (myelomeningocele with a neurogenic bladder) abnormality | 14 (18.2) | | Vesicoureteral reflux (VUR) | 10 (13) | | Anatomic anomaly (e.g., obstructive uropathy, bladder exstrophy, or a neurogenic bladder) | 10 (13) | | Bladder dysfunction representing with enuresis | 6 (7.8) | | Patients had undergone chronic hemodialysis | 4 (5.2) | | Urolithiasis | 3 (3.8) | | Others (malignancy, etc.) | 4 (5.2) |
|
|
